Insulin-like growth factor-induced transcriptional activity of the skeletal alpha-actin gene is regulated by signaling mechanisms linked to voltage-gated calcium channels during myoblast differentiation.

IGF-I activates signaling pathways that increase the expression of muscle-specific genes in differentiating myoblasts. Induction of skeletal alpha-actin expression occurs during differentiation through unknown mechanisms. The purpose of this investigation was to examine the mechanisms that IGF-I uses to induce skeletal alpha-actin gene expression in C2C12 myoblasts. IGF-I increased skeletal alpha-actin promoter activity by 107% compared with the control condition. Ni(+) [T-type voltage-gated Ca(2+) channel (VGCC) inhibitor] reduced basal-induced activation of the skeletal alpha-actin promoter by approximately 84%, and nifedipine (L-type VGCC inhibitor) inhibited IGF-I-induced activation of the skeletal alpha-actin promoter by 29-48%. IGF-I failed to increase skeletal alpha-actin promoter activity in differentiating dysgenic (lack functional L-type VGCC) myoblasts; 30 mm K(+) and 30 mm K(+)+IGF-I increased skeletal alpha-actin promoter activity by 162% and 76% compared with non-IGF-I or IGF-I-only conditions, respectively. IGF-I increased calcineurin activity, which was inhibited by cyclosporine A. Further, cyclosporine A inhibited K(+)+IGF-I-induced activation of the skeletal alpha-actin promoter. Constitutively active calcineurin increased skeletal alpha-actin promoter activity by 154% and rescued the nifedipine-induced inhibition of L-type VGCC but failed to rescue the Ni(+)-inhibition of T-type VGCC. IGF-I-induced nuclear factor of activated T-cells transcriptional activity was not inhibited by nifedipine or Ni(+). IGF-I failed to increase serum response factor transcriptional activity; however, serum response factor activity was reduced in the presence of Ni(+). These data suggest that IGF-I-induced activation of the skeletal alpha-actin promoter is regulated by the L-type VGCC and calcineurin but independent of nuclear factor of activated T-cell transcriptional activity as C2C12 myoblasts differentiate into myotubes.

[1]  J. Molkentin,et al.  Altered Skeletal Muscle Phenotypes in Calcineurin Aα and Aβ Gene-Targeted Mice , 2003, Molecular and Cellular Biology.

[2]  R. Schwartz,et al.  Calcium/Calmodulin-dependent Protein Kinase Activates Serum Response Factor Transcription Activity by Its Dissociation from Histone Deacetylase, HDAC4 , 2003, Journal of Biological Chemistry.

[3]  G. Pavlath,et al.  Calcineurin initiates skeletal muscle differentiation by activating MEF2 and MyoD. , 2003, Differentiation; research in biological diversity.

[4]  M. Estrada,et al.  Dihydropyridine Receptors as Voltage Sensors for a Depolarization-evoked, IP3R-mediated, Slow Calcium Signal in Skeletal Muscle Cells , 2003, The Journal of general physiology.

[5]  D. Burrin,et al.  Acute IGF-I infusion stimulates protein synthesis in skeletal muscle and other tissues of neonatal pigs. , 2002, American journal of physiology. Endocrinology and metabolism.

[6]  S. Rivkees,et al.  Reduction in Intracellular Calcium Levels Inhibits Myoblast Differentiation* , 2002, The Journal of Biological Chemistry.

[7]  F. Booth,et al.  GSK-3β negatively regulates skeletal myotube hypertrophy , 2002 .

[8]  F. Booth,et al.  Multiple signaling pathways mediate LIF-induced skeletal muscle satellite cell proliferation. , 2002, American journal of physiology. Cell physiology.

[9]  P. Lory,et al.  α1H mRNA in single skeletal muscle fibres accounts for T‐type calcium current transient expression during fetal development in mice , 2002, The Journal of physiology.

[10]  D. Allen,et al.  Different Pathways Regulate Expression of the Skeletal Myosin Heavy Chain Genes* , 2001, The Journal of Biological Chemistry.

[11]  M. Estrada,et al.  IP(3) receptor function and localization in myotubes: an unexplored Ca(2+) signaling pathway in skeletal muscle. , 2001, Journal of cell science.

[12]  M. Rudnicki,et al.  The potential of muscle stem cells. , 2001, Developmental cell.

[13]  S. Adi,et al.  Opposing early inhibitory and late stimulatory effects of insulin‐like growth factor‐I on myogenin gene transcription , 2000, Journal of cellular biochemistry.

[14]  J. Molkentin,et al.  A Calcineurin-NFATc3-Dependent Pathway Regulates Skeletal Muscle Differentiation and Slow Myosin Heavy-Chain Expression , 2000, Molecular and Cellular Biology.

[15]  C. Bader,et al.  T-type alpha 1H Ca2+ channels are involved in Ca2+ signaling during terminal differentiation (fusion) of human myoblasts. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Schwartz,et al.  β1-Integrin and PI 3-kinase regulate RhoA-dependent activation of skeletal α-actin promoter in myoblasts , 2000 .

[17]  M. Hohenegger,et al.  Dihydropyridine‐induced Ca2+ release from ryanodine‐sensitive Ca2+ pools in human skeletal muscle cells , 2000, The Journal of physiology.

[18]  J. Liberona,et al.  IP(3) receptors, IP(3) transients, and nucleus-associated Ca(2+) signals in cultured skeletal muscle. , 2000, American journal of physiology. Cell physiology.

[19]  Valerie Horsley,et al.  Calcineurin Activity Is Required for the Initiation of Skeletal Muscle Differentiation , 2000, The Journal of cell biology.

[20]  P. Mertz,et al.  Calcineurin: form and function. , 2000, Physiological reviews.

[21]  A. Musarò,et al.  IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1 , 1999, Nature.

[22]  Richard P. Harvey,et al.  Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway , 1999, Nature.

[23]  O. Delbono,et al.  Insulin‐like growth factor‐1 enhances rat skeletal muscle charge movement and L‐type Ca2+ channel gene expression , 1999, The Journal of physiology.

[24]  J. Bruton,et al.  Insulin increases near-membrane but not global Ca2+ in isolated skeletal muscle. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Schwartz,et al.  RhoA Signaling via Serum Response Factor Plays an Obligatory Role in Myogenic Differentiation* , 1998, The Journal of Biological Chemistry.

[26]  F. Booth,et al.  Activation of the skeletal α-actin promoter during muscle regeneration , 1998, Journal of Muscle Research & Cell Motility.

[27]  M. Messi,et al.  Regulation of Mouse Skeletal Muscle L-Type Ca2+Channel by Activation of the Insulin-Like Growth Factor-1 Receptor , 1997, The Journal of Neuroscience.

[28]  E. Olson,et al.  Wild-type myoblasts rescue the ability of myogenin-null myoblasts to fuse in vivo. , 1997, Developmental biology.

[29]  J. Florini,et al.  The Mitogenic and Myogenic Actions of Insulin-like Growth Factors Utilize Distinct Signaling Pathways* , 1997, The Journal of Biological Chemistry.

[30]  J R Florini,et al.  Growth hormone and the insulin-like growth factor system in myogenesis. , 1996, Endocrine reviews.

[31]  R. Schwartz,et al.  SRF and TEF-1 control of chicken skeletal alpha-actin gene during slow-muscle hypertrophy. , 1996, The American journal of physiology.

[32]  V. Andrés,et al.  Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis , 1996, The Journal of cell biology.

[33]  E. Hardeman,et al.  Delineation of a slow-twitch-myofiber-specific transcriptional element by using in vivo somatic gene transfer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  K. Beam,et al.  Calcium transients associated with the T type calcium current in myotubes , 1994, The Journal of general physiology.

[35]  H. Blau,et al.  Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy , 1994, The Journal of cell biology.

[36]  T. Mcdonald,et al.  Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. , 1994, Physiological reviews.

[37]  B. Flucher,et al.  Coordinated development of myofibrils, sarcoplasmic reticulum and transverse tubules in normal and dysgenic mouse skeletal muscle, in vivo and in vitro. , 1992, Developmental biology.

[38]  B. Flucher,et al.  Dihydropyridine receptor alpha subunits in normal and dysgenic muscle in vitro: expression of alpha 1 is required for proper targeting and distribution of alpha 2 , 1991, The Journal of cell biology.

[39]  J. Florini,et al.  Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. , 1991, Molecular endocrinology.

[40]  B. Adams,et al.  Intramembrane charge movement restored in dysgenic skeletal muscle by injection of dihydropyridine receptor cDNAs , 1990, Nature.

[41]  P. Rotwein,et al.  Insulin-like growth factors (IGF) in muscle development. Expression of IGF-I, the IGF-I receptor, and an IGF binding protein during myoblast differentiation. , 1989, The Journal of biological chemistry.

[42]  L. Kedes,et al.  The sarcomeric actin CArG-binding factor is indistinguishable from the c-fos serum response factor , 1989, Molecular and cellular biology.

[43]  K. Campbell,et al.  Specific absence of the alpha 1 subunit of the dihydropyridine receptor in mice with muscular dysgenesis. , 1989, The Journal of biological chemistry.

[44]  L. Kedes,et al.  A common factor regulates skeletal and cardiac alpha-actin gene transcription in muscle , 1988, Molecular and cellular biology.

[45]  C. Knudson,et al.  Effect of postnatal development on calcium currents and slow charge movement in mammalian skeletal muscle , 1988, The Journal of general physiology.

[46]  H. Blau,et al.  Differential patterns of transcript accumulation during human myogenesis , 1987, Molecular and cellular biology.

[47]  L. Kedes,et al.  Multiple 5'-flanking regions of the human alpha-skeletal actin gene synergistically modulate muscle-specific expression , 1987, Molecular and cellular biology.

[48]  K. Beam,et al.  A lethal mutation in mice eliminates the slow calcium current in skeletal muscle cells , 1986, Nature.

[49]  G. Yagil,et al.  Control of myogenesis in vitro by Ca 2 + concentration in nutritional medium. , 1969, Experimental cell research.

[50]  E. Perez-Reyes.  Molecular physiology of low-voltage-activated t-type calcium channels. , 2003, Physiological reviews.

[51]  B. Flucher,et al.  Dihydropyridine Receptor a Subunits in Normal and Dysgenic Muscle In Vitro : Expression ofai Is Required for Proper Targeting and Distribution ofa 2 , 2002 .

[52]  D. Allen,et al.  Intracellular Calcium and Myosin Isoform Transitions CALCINEURIN AND CALCIUM-CALMODULIN KINASE PATHWAYS REGULATE PREFERENTIAL ACTIVATION OF THE IIa MYOSIN HEAVY CHAIN PROMOTER* , 2002 .

[53]  C. Bader,et al.  T-type a1H Ca21 channels are involved in Ca21 signaling during terminal differentiation (fusion) of human myoblasts , 2000 .

[54]  B. Black,et al.  Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. , 1998, Annual review of cell and developmental biology.

[55]  P. Hogan,et al.  Transcription factors of the NFAT family: regulation and function. , 1997, Annual review of immunology.

[56]  E. Schultz,et al.  Skeletal muscle satellite cells. , 1994, Reviews of physiology, biochemistry and pharmacology.

[57]  L. Kedes,et al.  The human skeletal alpha-actin gene is regulated by a muscle-specific enhancer that binds three nuclear factors. , 1992, Gene expression.

[58]  L. Kedes,et al.  Developmental regulation of contractile protein genes. , 1989, Annual review of physiology.